Pfizer will sell drugs to Medicaid and set prices of new drugs at “Most Favored Nation” levels, the lowest price made available in peer countries. The effort comes as Trump has been haranguing drugmakers for months to lower their prices for US patients. Trump tried unsuccessfully to institute “Most Favored Nation” pricing during his first term. Ramification warningThe drug industry has warned any “Most Favored Nation” directives could have serious ramifications. The president does not have the legal authority to require drug companies to set their products at “Most Favored Nation” prices.